Company: FWDI
Filing Date: 2025-06-10
Form Type: PRE 14A
Source: 0001683168-25-004370
Chunk: 11

Company: Forward Industries, Inc.
Filing Date: 2025-06-10
Form: PRE 14A
Chunk 11
---
 on the following pages.

<div align='center'>The Board recommends a vote “ For” the election of the nominated slate of directors.</div>

| 7 |

<div align='center'>DIRECTORS AND EXECUTIVE OFFICERS</div>

The following table represents
our Board as of the record date.

| Name           | Age | Appointed     |
| Sangita Shah   |  59 | February 2015 |
| Sharon Hrynkow |  64 | February 2022 |
| Keith Johnson  |  67 | May 2025      |

Director Nominee Biographies

Sangita Shah. Ms. Shah currently serves
as director and owner of Odyssean Enterprises Limited, a private advisory and investment company, in addition to serving as non-executive
chairman of Kinovo PLC, (FTSE: KINO), a leading UK provider of specialist property services centered on safety and regulatory compliance
and is lead director of Inspired PLC, (FTSE: INSE) UK’s leading energy and sustainability advisor. She was previously non-executive
chairman of RA International PLC, (FTSE: RAI) a leading provider of services to remote locations in Africa and the Middle East and board
director and chair of ESG for Ten Entertainment PLC (FTSE: TEN), an operator of entertainment centres. Ms. Shah also serves as a board
director of Quoted Companies Alliance which represents over 90% of small and midsized market cap FTSE companies. Ms. Shah previously worked
in seed/mezzanine financing and strategic investments within the environmental and technology sectors following a number of senior roles
held at KPMG, Ernst & Young, Unilever and Mars Inc. She has spent 20 years volunteering for Windsor Leadership, a charity based on
providing leadership courses at Windsor Castle and established by the Duke of Edinburgh and Professor Charles Handy. Ms. Shah was selected
as a director for her board and accounting experience, and she also serves as our Chairman. She previously served as our Lead Director.

Sharon Hrynkow. Dr. Sharon Hrynkow is President
& CEO of Life Science Works, a firm that empowers life science entrepreneurs by securing non-dilutive funding. Prior roles include
Chief Scientific Officer and Senior VP for Medical Affairs at Cyclo Therapeutics (Nasdaq: CYTH, acquired by RFL) where she launched
and led its drug development programs from 2015 to 2022;